long intergenic non-protein coding RNA 928Genealiases: []
Q-omics provides the consensus-scored LINC00928 profile across patient tissues and cancer cell-line models. LINC00928 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in UCS. Among the 18 cancer types available for tumor–normal comparison, LINC00928 is differentially expressed in 5, with the highest sampling consensus in KIRC. Additionally, LINC00928 RNA expression shows 11,483 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight UCS, KIRC, and GBM as cancer lineages where LINC00928 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00928 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00928 survival associations across molecular data types. LINC00928 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00928 RNA expression–survival associations across cancer types. High LINC00928 expression shows unfavorable associations in THYM, MESO, COAD, KIRC and STAD, but favorable associations in UCS. The UCS Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .003). Together, the overview and detailed table identify UCS as the clearest survival context for LINC00928 RNA expression.
This table summarizes LINC00928 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00928. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00928 shows lower tumor expression in HNSC and higher tumor expression in KIRC, LUSC, KICH and LUAD. The KIRC box plot shows higher LINC00928 RNA expression in tumor versus normal tissue (log2 FC = +0.045, t-test p < 0.001).
This table shows molecular features associated with LINC00928 in patient tissues and cancer cell lines. In patient samples, LINC00928 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
